NKT cells are important mediators of hepatic ischemia-reperfusion injury

Transpl Immunol. 2017 Dec:45:15-21. doi: 10.1016/j.trim.2017.08.002. Epub 2017 Aug 7.

Abstract

Introduction: IRI results from the interruption then reinstatement of an organ's blood supply, and this poses a significant problem in liver transplantation and resectional surgery. In this paper, we explore the role T cells play in the pathogenesis of this injury.

Materials & methods: We used an in vivo murine model of warm partial hepatic IRI, genetically-modified mice, in vivo antibody depletion, adoptive cell transfer and flow cytometry to determine which lymphocyte subsets contribute to pathology. Injury was assessed by measuring serum alanine aminotransfersase (ALT) and by histological examination of liver tissue sections.

Results: The absence of T cells (CD3εKO) is associated with significant protection from injury (p=0.010). Through a strategy of antibody depletion it appears that NKT cells (p=0.0025), rather than conventional T (CD4+ or CD8+) (p=0.11) cells that are the key mediators of injury.

Discussion: Our results indicate that tissue-resident NKT cells, but not other lymphocyte populations are responsible for the injury in hepatic IRI. Targeting the activation of NKT cells and/or their effector apparatus would be a novel approach in protecting the liver during transplantation and resection surgery; this may allow us to expand our current criteria for surgery.

Keywords: Acute liver injury; Ischemia-reperfusion injury (IRI); Liver surgery; NKT cells; Natural killer cells; T cells; Transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD3 Complex / genetics
  • Homeodomain Proteins / genetics
  • Humans
  • Liver / metabolism
  • Liver / pathology*
  • Liver Transplantation*
  • Lymphocyte Depletion
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Natural Killer T-Cells / immunology*
  • Reperfusion Injury / immunology*
  • T-Lymphocytes / immunology*

Substances

  • CD3 Complex
  • Homeodomain Proteins
  • RAG-1 protein